Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Kidney+transplant%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Kidney+transplant%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=%22Kidney+transplant%22&type=Subject
PubPharm (188)
1
A randomised controlled investigation into the efficacy of heme arginate in improving primary graft function in deceased donor kidney transplantation : Heme arginate in transplantation - a multi-centre blinded parallel-group randomised trial of heme arginate versus placebo to reduce delayed graft function in kidney transplant recipients. (The HOT 2 Trial). - The HOT 2 Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Efficacy and safety of human plasma-derived C1-esterase inhibitor as add-on to standard of care for the treatment of refractory antibody mediated rejection (AMR) in adult renal transplant recipients : A Double-blind, Randomized-Withdrawal, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Human Plasma-Derived C1-esterase Inhibitor as Add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection in Adult Renal Transplant Recipients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
PlasmaLyte Usage and assessment of kidney Transplant Outcomes in children: the PLUTO trial : PlasmaLyte Usage and assessment of kidney Transplant Outcomes in children: the PLUTO trial - PLUTO
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A randomised controlled investigation into the efficacy of heme arginate in improving primary graft function in deceased donor kidney transplantation : Heme arginate in transplantation - a multi-centre blinded parallel-group randomised trial of heme arginate versus placebo to reduce delayed graft function in kidney transplant recipients. (The HOT 2 Trial). - The HOT 2 Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Efficacy and safety of human plasma-derived C1-esterase inhibitor as add-on to standard of care for the treatment of refractory antibody mediated rejection (AMR) in adult renal transplant recipients : A Double-blind, Randomized-Withdrawal, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Human Plasma-Derived C1-esterase Inhibitor as Add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection in Adult Renal Transplant Recipients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
PlasmaLyte Usage and assessment of kidney Transplant Outcomes in children: the PLUTO trial : PlasmaLyte Usage and assessment of kidney Transplant Outcomes in children: the PLUTO trial - PLUTO
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A Phase I/IIa Study to Evaluate the Safety and Tolerability of an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (TX200-TR101) in Living Donor Renal Transplant Recipients : A Multicentre, Open-Label, Single Ascending Dose, Dose-Ranging, Phase I/IIa Study to Evaluate the Safety and Tolerability of an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (TX200-TR101) in Living Donor Renal Transplant Recipients - A phase 1/2a study of TX200-TR101 in renal transplant recipients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Study in highly sensitised kidney transplant patients with a high degree of antibodies against the donor's kidney to see the efficacy and safety of imlifidase to temporarily remove the antibodies and enable the transplantation. : A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase treatment, including non-comparative registry and concurrent reference cohorts
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Study in highly sensitised kidney transplant patients with a high degree of antibodies against the donor's kidney to see the efficacy and safety of imlifidase to temporarily remove the antibodies and enable the transplantation. : A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase treatment, including non-comparative registry and concurrent reference cohorts
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Study in highly sensitised kidney transplant patients with a high degree of antibodies against the donor's kidney to see the efficacy and safety of imlifidase to temporarily remove the antibodies and enable the transplantation. : A controlled, open-label post-authorisation efficacy and safety study in imlifidase desensitised kidney transplant patients with positive crossmatch against a deceased donor prior to imlifidase treatment, including non-comparative registry and concurrent reference cohorts
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[19]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Medienart
188
Aufsätze
188
E-Artikel
188
E-Ressourcen
Zeitschriftentitel
188
WHO International Clinical Trials Registry Plat...
Thema
188
610
Recruitment Status: Authorised-recruitment may ...
188
Study Type: Interventional
46
Phase: Phase 3
46
Phase: Phase 4
34
Phase: Phase 2
12
Phase: Phase 1
10
Medical Condition: Chronic Active Antibody-Medi...
8
Medical Condition: Antibody-mediated rejection ...
8
Medical Condition: Prevention of immune mediate...
6
Medical Condition: Antibody-mediated rejection ...
6
Medical Condition: MedDRA version: 20.0Level: P...
6
Medical Condition: kidney transplantation;Thera...
4
Medical Condition: Immunosuppression after kidn...
4
Medical Condition: PROPHYLAXIS OF REJECTION AFT...
4
Medical Condition: Prevention of CMV disease in...
4
Medical Condition: kidney transplantation;Thera...
2
Medical Condition: Acute rejection prophylaxis ...
2
Medical Condition: Antibody and cellular respon...
2
Medical Condition: Antibody-mediated rejection ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
106
2020-
82
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
180
Englisch
4
Spanisch
2
Französisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...